Dr. Reddys Laboratories Ltd.

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddy’s Laboratories has informed that it enclosed the applicable disclosure on related party transactions for the half year ended March 31, 2022, in the requisite format.

The above information is a part of company’s filings submitted to BSE.